Chris Cain's Insider Trades & SAST Disclosures

Chris Cain's most recent trade in Cogent Biosciences Inc was a trade of 44,700 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 5, 2024.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Cogent Biosciences Inc
Christopher W. Cain Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jun 2024 44,700 44,700 - - Stock Option (Right to Buy)
Cogent Biosciences Inc
Christopher W. Cain Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jun 2023 36,700 36,700 - - Stock Option (Right to Buy)
Cogent Biosciences Inc
Christopher W. Cain Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jun 2022 30,700 30,700 - - Stock Option (Right to Buy)
Cogent Biosciences Inc
Christopher W. Cain Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Mar 2021 60,000 60,000 - - Stock Option (Right to Buy)
Cogent Biosciences Inc
Chris Cain Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Aug 2020 28,661 28,661 - - Director Stock Option (Right to Buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades